Tag: PASADENA

Interview: Are we on a path towards a cure for Parkinson’s?

Expert
Prof. Andrew Siderowf, Penn Medicine, Philadelphia, PA, USA

2 April 2024 15:59

Prasinezumab in Parkinson’s disease: delayed-start analysis of PASADENA trial

Presented By
Dr Gennaro Pagano, King’s College London, UK
Trial
Phase 2, PASADENA
Conference
AAN 2022
Type
Peer-reviewed article

2 June 2022 17:18

Effect of prasinezumab on motor features in early PD

Trial
Phase 2, PASADENA
Conference
EAN 2021
Type
Peer-reviewed article

18 August 2021 11:36
site created by:   

Ā© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com